Introduction
The in-hospital use of various antibiotics is an ever growing concern for several reasons. Costly yet indispensible, antibiotic drugs attribute to a major proportion of the inflating drug budget. In hospitals this poses challenges for the administrators as well as purchase officers of health care services . [1] Main aim of any drug utilization research is to assess the rational use of drugs. To achieve this aim, drug audit at regular intervals may be inevitable. Drug utilization studies can be classified as descriptive and analytical studies. Descriptive studies assess and elaborate patterns of drug utilization with an aim to identify grey areas of research in this field. Analytical studies co-relate data on drug utilization to outcome of treatment, hospital morbidity, resistance patterns and quality of health-care, thus achieving the aim of rationalizing the therapy. Drug utilization research not only provides insight to the rationality of drug use but also hints whether a certain drug therapy provides value for money. The results of such pharmaco-economic studies , help to set priorities for the appropriate allocation of health care budgets. [2] It is therefore an important tool to study the use of drugs in clinical settings in various populations and its impact on health-care system as a whole. [3, 4] The cost of health care is a matter of major concern in developing countries. [5] Antibiotic drug utilization patterns are necessary for a constructive approach to address issues that arise from availability of multiple antibiotics. [6] Studies have concluded that ,although in most cases the choice of antibiotics is in accordance with the guidelines which is especially true for leading medical centers; yet there was still unwarranted overuse of prophylactic agents which may account to increased costs to the hospital. [7] The problem may turn graver with the development of resistance to antibiotics, ecological imbalances and super-infections in various patients. [8, 9] Main limitation in drug utilization study is that each formulation has different unit dose of daily administration, therefore a specific standardized method should be used in the evaluation of in-hospital antibiotic use. Nordic Council on Medicines (Uppsala, Sweden) along with Norwegian researchers developed the DDD is a measurement unit that was in 1976. The DDD does not necessarily mean recommended or prescribed daily dose for any patients but is simply the assumed average maintenance dose per day for a drug in its main indication and route, for adults. It is a measurement unit recommended to be used during drug utilization studies. [10] The ATC (anatomic-therapeutic-chemical) classification is a classification that assigns code letters and numbers to drugs as per their pharmacological category. DDD is be assigned only for drugs that already have an ATC code. DDD although may not reflect the prescribed daily dose as mentioned previously, however they provide a standard unit of measurement independent formulation ,units, dosing schedule .They hereby enable the researcher to compare between variety of population groups. DDD/100 bed-days is an estimate of consumption of drugs among hospitalized patients. [11, 12] The present study therefore evaluates the injectable antibiotic utilization as six-monthly trends in a Government set-up of a tertiary care teaching hospital in India. The aims of the study were: (a) To assess the use of parenteral/injectable antibiotics, in a tertiary care government hospital in India on sixmonthly basis over one year.
ATC/DDD method to assess the injectable antibiotics utilization in a tertiary
(b) To assess the impact of such variation in antibiotic utilization on expenditure over antibiotics by the drug store.
II. Material And Methods
This was a partly prospective and partly retrospective drug utilization study. It was conducted in a, 1190 bedded government tertiary care teaching hospital (excluding pediatric wards). The study is a part of a larger study that was approved by the ethics committee (ethical app no: BJMC/IEC/Pharmac/1210115-17, dt:23-12-2010).And was done in six monthly phases as January 2013 to June 2013 and July 2013 to December 2013 .The data for this study was over twelve months and missing and cost data was recorded retrospectively. Data on drug utilization in terms of dose, duration and indications was recorded from antibiotic indent forms , patient records and drug store records. Only total amount of antibiotic consumed patient-wise and ward-wise was noted. Data missing due to technical limitations was collected retrospectively. The drug utilization was computed as DDD/100 bed−days. [13, 14, 15] The data was evaluated by Microsoft Excel software for analysis. DDD/100 bed−days = Drug consumption in the study period (mg) × 100
Assigned DDD (mg) x ( Period of study × Bed strength × Average occupancy) The expenditure on antibiotics was calculated according to the rate Government rate-contract prices of antibiotics available with the drug store .These prices remains constant for three years. 
IV. Discussion
Antibiotic consumption of any hospital is a dynamic data that is governed by many factors like change in sensitivity patterns of various local microbes, addition of new drug molecules in the market, their availability in hospital pharmacy/drug stores and changing treatment guidelines. Therefore antibiotic consumption studies are done mainly to identify areas of improvement, to compare antimicrobial use across wards and hospitals, [17] to study impact of interventions [16] and capture attention of healthcare professionals on its rational use. [18] The data of the present study was recorded over twelve months .In the first six months i.e January to June, a total of 30973 in-patients were recorded; whereas there was an increase in number in in-patients in the next six months (33813 in-patients).The antibiotics in both the periods antibiotics were most frequently used for post -surgical patients (29.25% and 21.16 % respectively) by various surgical departments (viz. surgery, orthopedics and obstetrics -gynecology). Deshmukh V et al., also report maximum antimicrobial utilization done for surgical chemoprophylaxis [19] . Ceftriaxone sodium was the most utilized injectable antibiotic amounting to 2.607 DDD/100 bed-days in January-June 2013 and 2.136 DDD/100 bed-days in July-December 2013. This finding is in accordance with the results of another study ,but the researchers in that study included Ceftriaxone and combination of Ceftriaxone + Sulbactum collectively for reporting . [20] A study by Mittal et al concluded that beta-lactams were maximally used ,but the researchers had included cephalosporins collectively in beta-lactam group. [21] A study by Paul et al also concludes the high use of Ceftriaxone . [22] Amikacin (1.438 DDD/100 bed-days) was the second most commonly used antibiotic in the period July -December 2013 as most of the utilization was by surgical patients.A high use of Amikacin was reported by Tripathi et al. in laprotomy patients . [23] Colistin was the least used injectable in July-December. period ( 0.00024 DDD/100 bed-days ) followed Linezolid as both are reserve antibiotics for resistant pathogens. Colistin use could not be commented in the January.-June 2013 period as it was not available in the drug store in that period. There was a definite decrease in the utilization of injectables like -Imipenem + Cilastin , Clarithromycin, Linezolid , Meropenem, Piperacillin + Tazobactum, Teicoplanin and Vancomycin. During the study period several restrictions were imposed on the indent of these drugs, therefore issued only if use was justified and rational as per the culture sensitivity. This reflected as a gradual but a definite decrease in utilization of these drugs. Antibiotic restrictions although are not favored by certain authors [24, 25] ; yet if the restrictions are imposed for rational utilization of antibiotics it is still justified. There was a significant reduction in costs on antibiotics Rs.21,14,952 (p=0.011) in the period June to December although the inpatient admissions had increased. This study is a part of a larger study which takes into consideration the change in resistance patterns and patient outcome patterns due to antibiotic restrictions.
V. Conclusion
The present study concludes that Ceftrixone was the most commonly used injectable antibiotic followed by Amikacin in the year 2013 in our hospital. Consumption of these injectable antibiotics did not vary much as they are integral part of treatment as per local sensitivity data and are used empirically .The reserve drug like Colistin and Linezolid are used sparingly as per their indications. Restriction on antibiotics take time to show effect on utilization patterns hence a six-monthly analysis should be done to overview changes but definitely helps in resource limited setting and may help to minimize cost while concurrently assisting in providing optimum healthcare .The limitation of the study was that it could not comment on the change in the resistance patterns due to formulary restrictions.
